132 related articles for article (PubMed ID: 37610148)
21. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
22. Influence of p16 Protein Immunostaining on Histopathological Features of Pleomorphic Adenoma and Carcinoma ex- Pleomorphic Adenoma.
Magalhaes IA; Barbosa KC; Costa GAJ; Oliveira Filho OV; Da Silva Junior JE; Gonzaga Silva LF; Juaçaba SF; Sousa FB; Barros Silva PG
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3815-3824. PubMed ID: 38019239
[TBL] [Abstract][Full Text] [Related]
23. Soluble E-cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma.
Chen W; Ye S; Wang X; Qian J; Xia L; Tian Z
J Oral Pathol Med; 2023 Jan; 52(1):63-71. PubMed ID: 36445289
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma ex-pleomorphic adenoma of the parotid gland consisting of high-grade salivary duct carcinoma and keratinizing squamous cell carcinoma.
Magaki SD; Bhuta S; Abemayor E; Nabili V; Sepahdari AR; Lai CK
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):e169-73. PubMed ID: 25782724
[TBL] [Abstract][Full Text] [Related]
25. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of carcinoma ex pleomorphic adenoma compared to de novo adenocarcinoma of major salivary glands.
Patel EJ; Oliver JR; Liu C; Tam M; Givi B
J Surg Oncol; 2021 Feb; 123(2):446-455. PubMed ID: 33145786
[TBL] [Abstract][Full Text] [Related]
27. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
28. Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.
Yu W; Ding C; Li K
Oral Oncol; 2023 Nov; 146():106541. PubMed ID: 37595449
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
Di Palma S
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
[TBL] [Abstract][Full Text] [Related]
30. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology.
Singh K; Agarwal C; Pujani M; Verma P; Chauhan V
Diagn Cytopathol; 2017 Jul; 45(7):651-654. PubMed ID: 28261993
[TBL] [Abstract][Full Text] [Related]
32. Carcinoma ex pleomorphic adenoma of the upper lip.
Dyalram D; Huebner T; Papadimitriou JC; Lubek J
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):364-7. PubMed ID: 22209228
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
Kimura TC; Scarini JF; Lavareze L; Kowalski LP; Coutinho-Camillo CM; Krepischi ACV; Egal ESA; Altemani A; Mariano FV
Head Neck; 2024 May; 46(5):985-1000. PubMed ID: 38482546
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic adenoma: the great mimicker of malignancy.
Hernandez-Prera JC; Skálová A; Franchi A; Rinaldo A; Vander Poorten V; Zbären P; Ferlito A; Wenig BM
Histopathology; 2021 Sep; 79(3):279-290. PubMed ID: 33368685
[TBL] [Abstract][Full Text] [Related]
36. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
[TBL] [Abstract][Full Text] [Related]
37. Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.
Kim H; Eun S; Jeong WJ; Ahn SH; Bae YJ; Lee JS; Kim H
Sci Rep; 2022 Aug; 12(1):13383. PubMed ID: 35927424
[TBL] [Abstract][Full Text] [Related]
38. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
[TBL] [Abstract][Full Text] [Related]
39. Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.
Covinsky M; Cai Z; Ambelil M; Liu J; Zhu H
Head Neck Pathol; 2018 Mar; 12(1):82-88. PubMed ID: 28589437
[TBL] [Abstract][Full Text] [Related]
40. Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma.
de Lima-Souza RA; Scarini JF; Lavareze L; Emerick C; Crescencio LR; Domingues RR; Paes Leme AF; Mariz BALA; Bastos DC; Machado RA; Tincani AJ; Del Negro A; Chone CT; Kowalski LP; Egal ESA; Altemani A; Mariano FV
Oral Dis; 2023 Apr; 29(3):1017-1027. PubMed ID: 34902207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
